SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,294.96 -19.63
( -0.03%)

Global Indices

Nasdaq

51,699.28 -99.76
(-0.19%)

Dow Jones

7,668.45 9.69
(0.13%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,654.81 -161.33
(-1.49%)

Forex

USD-INR

95.87 0.21
(0.22%)

EUR-INR

110.00 -0.22
(-0.20%)

GBP-INR

128.18 -0.44
(-0.35%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

658.9991894

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

14.81

98069.81

EPS(TTM)

Face Value()

Div & Yield %

144.81

0.84

Back

Apollo Ingredients reports standalone net profit of Rs 1.22 crore in the June 2026 quarter

Aug 11,2026

Net profit of Apollo Ingredients reported to Rs 1.22 crore in the quarter ended June 2026 as against net loss of Rs 0.09 crore during the previous quarter ended June 2025. Sales rose 841.07% to Rs 5.27 crore in the quarter ended June 2026 as against Rs 0.56 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5.27	0.56	841
OPM %	24.67	-16.07	-
PBDT	1.30	-0.09	LP
PBT	1.22	-0.09	LP
NP	1.22	-0.09	LP

74,294.96 -19.63 ( -0.03%)

51,699.28 -99.76 (-0.19%)

7,668.45 9.69 (0.13%)

65,040.24 903.99 (1.41%)

10,654.81 -161.33 (-1.49%)

95.87 0.21 (0.22%)

110.00 -0.22 (-0.20%)

128.18 -0.44 (-0.35%)

0.61 0.00 (-0.09%)